2021 annual financial data
BioNexus Gene Lab 2021 Operating cash flow
Direct answer
Operating cash flow was 9,161 USD.
Operating income was 1,055,827 USD and net income was 751,571 USD.
Operating cash flow was 9,161 USD.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,362,567 USD
- Operating income
- 1,055,827 USD
- Net income
- 751,571 USD
- Operating cash flow
- 9,161 USD